TELA Bio, Inc. (TELA) Results Beat, Piper Sandler Sees an Inflection Coming with Procedure Growth
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $20.00 price target on TELA Bio, Inc. (NASDAQ: TELA) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
